An informational overview examining ingredient-level research context, Supplement Facts interpretation, and evaluation factors consumers consider when researching cognitive health supplement options ...
A 2026 informational consumer research report examining FocusMax cognitive support marketing claims, ingredient-level research context, proprietary blend transparency, pricing disclosures, and verific ...
The US Food and Drug Administration has turned down an application to include new clinical data in the label of Lundbeck/Takeda’s Brintellix supporting its use to treat the cognitive symptoms of major ...
The open-label study evaluated the safety and tolerability, biological activity, blood biomarkers and preliminary efficacy of COYA 301 in 8 patients with Alzheimer’s disease (AD). The ...
Donepezil, a medication that is approved to treat people with Alzheimer's disease, should not be prescribed for people with mild cognitive impairment without a genetic test. UCLA School of Nursing ...
Neura Cognitive Health Supplement: Ingredient Facts, Label Guide, And Consumer Information For 2026. An informational overview examining ingredient-level research context, Supplement Facts ...
New York, NY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Cognitive health concerns should be evaluated by a qualified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results